Early steroid withdrawal and kidney transplant outcomes in first-transplant and retransplant recipients
In retransplant recipients, the negative impacts of ESW on transplant outcomes appear to be non-negligible. A more conservatively tailored approach to ESW might be necessary for retransplant recipients.
Authors
- Mara McAdams‐DeMarco (ORCID: https://orcid.org/0000-0003-3013-925X)
- Krista L. Lentine (ORCID: https://orcid.org/0000-0002-9423-4849)
- Shaifali Sandal (ORCID: https://orcid.org/0000-0003-1941-0598)
- Dorry Lidor Segev (ORCID: https://orcid.org/0000-0002-1924-4801)
- Sunjae Bae (ORCID: https://orcid.org/0000-0003-0098-8816)
- Mark A. Schnitzler (ORCID: https://orcid.org/0000-0001-8547-5643)
- Yusi Chen (ORCID: https://orcid.org/0000-0001-6968-4664)
Institutions
- McGill University Health Centre (CA)
- Saint Louis University (US)
- New York University (US)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1093/ndt/gfae218
- Citations
- 7
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 3.80
Funders
- U.S. Department of Health and Human Services
- Hennepin Healthcare Research Institute
- National Institute on Aging
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases